These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 19822065)

  • 1. Disease-modifying anti-rheumatic drugs in rheumatoid arthritis and ankylosing spondylitis.
    Haibel H; Specker C
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S159-63. PubMed ID: 19822065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of ankylosing spondylitis with disease modifying antirheumatic drugs.
    van der Horst-Bruinsma IE; Clegg DO; Dijkmans BA
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S67-70. PubMed ID: 12463451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disease-modifying anti-rheumatic drugs for treatment of ankylosing spondylitis].
    Madsen OR; Egsmose C
    Ugeskr Laeger; 2009 Aug; 171(33):2268-72. PubMed ID: 19732504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of rheumatoid arthritis and ankylosing spondylitis.
    Braun J; Sieper J
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S146-7. PubMed ID: 19822062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical inquiries. Are DMARDs effective for rheumatologic diseases besides rheumatoid arthritis?
    Goodemote P; Jamieson B; Hoffman R
    J Fam Pract; 2007 Nov; 56(11):933-4, 937. PubMed ID: 17976342
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: a randomized, double-blind trial.
    Braun J; van der Horst-Bruinsma IE; Huang F; Burgos-Vargas R; Vlahos B; Koenig AS; Freundlich B
    Arthritis Rheum; 2011 Jun; 63(6):1543-51. PubMed ID: 21630245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-biologic disease-modifying antirheumatic drugs (DMARDs) improve pain in inflammatory arthritis (IA): a systematic literature review of randomized controlled trials.
    Steiman AJ; Pope JE; Thiessen-Philbrook H; Li L; Barnabe C; Kalache F; Kung T; Bessette L; Flanagan C; Haraoui B; Hochman J; Leclercq S; Mosher D; Thorne C; Bykerk V
    Rheumatol Int; 2013 May; 33(5):1105-20. PubMed ID: 23292213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of malignancy in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under immunosuppressive therapy: a single-center experience.
    Fantò M; Peragallo MS; Pietrosanti M; Di Rosa R; Picchianti Diamanti A; Salemi S; D'Amelio R
    Intern Emerg Med; 2016 Feb; 11(1):31-40. PubMed ID: 26099279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DMARDs (disease-modifying antirheumatic drugs)].
    Tanaka E; Yamanaka H
    Nihon Rinsho; 2013 Jul; 71(7):1199-206. PubMed ID: 23961667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription rheumatology practices among Mexican specialists.
    Goycochea-Robles MV; Arce-Salinas CA; Guzmán-Vázquez S; Cardiel-Ríos MH
    Arch Med Res; 2007 Apr; 38(3):354-9. PubMed ID: 17350489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-modifying anti-rheumatic drugs improve autonomic neuropathy in arthritis: DIANA study.
    Syngle A; Verma I; Krishan P; Garg N; Syngle V
    Clin Rheumatol; 2015 Jul; 34(7):1233-41. PubMed ID: 24928343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
    Rossini M; Viapiana O; Orsolini G; Fracassi E; Idolazzi L; Gatti D; Adami S; Govoni M
    Reumatismo; 2015 Mar; 66(4):285-303. PubMed ID: 25829189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-TNF alpha in the treatment of rheumatoid arthritis and ankylosing spondylitis].
    Lanfant-Weybel K; Lequerré T; Vittecoq O
    Presse Med; 2009 May; 38(5):774-87. PubMed ID: 19327945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic comparison of rheumatoid arthritis and ankylosing spondylitis: non-steroidal anti-inflammatory drugs.
    Poddubnyy D; Song IH; Sieper J
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S148-51. PubMed ID: 19822063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of methotrexate in patients with ankylosing spondylitis.
    Haibel H; Sieper J
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S128-31. PubMed ID: 21044446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and medical management of patients with rheumatoid arthritis and ankylosing spondylitis.
    Bodur H; Ataman S; Akbulut L; Evcik D; Kavuncu V; Kaya T; Günaydin R; Kuran B; Kotevoğlu N; Bal A; Aydoğ E; Altay Z; Uğurlu H; Kocabaş H; Olmez N; Yazgan P; Gürsoy S; Madenci E; Ozel S; Delialioğlu SU
    Clin Rheumatol; 2008 Sep; 27(9):1119-25. PubMed ID: 18357499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral treatment options for AS and PsA: DMARDs and small-molecule inhibitors.
    Chan J; Gladman D
    Best Pract Res Clin Rheumatol; 2018 Jun; 32(3):415-426. PubMed ID: 31171312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns in use and costs of conventional and biologic disease-modifying anti-rheumatic drugs in Australia.
    Donges E; Staatz CE; Benham H; Kubler P; Hollingworth SA
    Clin Exp Rheumatol; 2017; 35(6):907-912. PubMed ID: 28421991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of radiographic progression in rheumatoid arthritis by anti-rheumatic drugs (DMARDs)].
    Suzuki Y; Wakabayashi T; Saito E; Suwa A
    Clin Calcium; 2007 Apr; 17(4):546-52. PubMed ID: 17404484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Clin Geriatr Med; 2005 Aug; 21(3):649-69, viii. PubMed ID: 15911212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.